These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32036610)

  • 1. Mixed hemodiafiltration reduces erythropoiesis stimulating agents requirement in dialysis patients: a prospective randomized study.
    Pedrini LA; Comelli M; Ruggiero P; Feliciani A; Manfrini V; Cozzi G; Castellano A; Pezzotta M; Gatti G; Arazzi M; Auriemma L; di Benedetto A; Stuard S
    J Nephrol; 2020 Oct; 33(5):1037-1048. PubMed ID: 32036610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
    Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high-volume online mixed-hemodiafiltration on anemia management in dialysis patients.
    Pedrini LA; Zawada AM; Winter AC; Pham J; Klein G; Wolf M; Feuersenger A; Ruggiero P; Feliciani A; Barbieri C; Gauly A; Canaud B; Stuard S
    PLoS One; 2019; 14(2):e0212795. PubMed ID: 30794672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.
    Panichi V; Scatena A; Rosati A; Giusti R; Ferro G; Malagnino E; Capitanini A; Piluso A; Conti P; Bernabini G; Migliori M; Caiani D; Tetta C; Casani A; Betti G; Pizzarelli F
    Nephrol Dial Transplant; 2015 Apr; 30(4):682-9. PubMed ID: 25385719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST).
    van der Weerd NC; Den Hoedt CH; Blankestijn PJ; Bots ML; van den Dorpel MA; Lévesque R; Mazairac AH; Nubé MJ; Penne EL; ter Wee PM; Grooteman MP;
    PLoS One; 2014; 9(4):e94434. PubMed ID: 24743493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total Convection Affects Serum β2 Microglobulin and C-Reactive Protein but Not Erythropoietin Requirement following Post-Dilutional Hemodiafiltration.
    Movilli E; Camerini C; Gaggia P; Zubani R; Feller P; Salviani C; Facchini A; Cancarini G
    Am J Nephrol; 2015; 41(6):494-501. PubMed ID: 26278270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Not baseline but time-dependent erythropoiesis-stimulating agent responsiveness predicts cardiovascular disease in hemodialysis patients receiving epoetin beta pegol: A multicenter prospective PARAMOUNT-HD Study.
    Fujii H; Hamano T; Tsuchiya K; Kuragano T; Joki N; Tsuruya K; Honda H; Uemura Y; Nitta K;
    Int J Cardiol; 2023 Mar; 375():110-118. PubMed ID: 36592827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration.
    Stefánsson BV; Abramson M; Nilsson U; Haraldsson B
    Nephron Extra; 2012 Jan; 2(1):55-65. PubMed ID: 22619668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of anemia in hemodialysis patients treated by hemodiafiltration with high-volume on-line-prepared substitution fluid.
    Bonforte G; Grillo P; Zerbi S; Surian M
    Blood Purif; 2002; 20(4):357-63. PubMed ID: 12169845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of clinical and laboratory features in chronic dialysis patients treated with high-flux hemodialysis after switching to online hemodiafiltration.
    Orasan RA; Patiu IM; Anghel D; Bejan C; Iosub L; Totolici C; Pop M; Turcea C; Teodoru C; Orasan OH; Kacso IM; Gherman Caprioara M
    Int Urol Nephrol; 2013 Oct; 45(5):1415-22. PubMed ID: 23212146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of different hemodialysis modalities on hepcidin clearance in patients undergoing maintenance hemodialysis.
    Sun L; Hua RX; Wu Y; Zou LX
    Semin Dial; 2023; 36(3):240-246. PubMed ID: 35785435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: effect on ESA requirement.
    Bolasco PG; Ghezzi PM; Serra A; Corazza L; Murtas S; Mascia M; Cossu M; Ferrara R; Cogoni G; Cadinu F; Casu D; Contu B; Passaghe M; Ghisu T; Ganadu M; Logias F
    Blood Purif; 2011; 31(4):235-42. PubMed ID: 21242676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomedical system dynamics to improve anemia control with darbepoetin alfa in long-term hemodialysis patients.
    McCarthy JT; Hocum CL; Albright RC; Rogers J; Gallaher EJ; Steensma DP; Gudgell SF; Bergstralh EJ; Dillon JC; Hickson LJ; Williams AW; Dingli D
    Mayo Clin Proc; 2014 Jan; 89(1):87-94. PubMed ID: 24388026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of Erythropoiesis-Stimulating Agent Use in European Hemodialysis Patients: The Dialysis Outcomes and Practice Patterns Study.
    Fuller DS; Robinson BM; Locatelli F; Pisoni RL
    Nephron; 2018; 140(1):24-30. PubMed ID: 29945128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved iron utilization and reduced erythropoietin resistance by on-line hemodiafiltration.
    Lin CL; Huang CC; Yu CC; Wu CH; Chang CT; Hsu HH; Hsu PY; Yang CW
    Blood Purif; 2002; 20(4):349-56. PubMed ID: 12169844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial.
    Locatelli F; Altieri P; Andrulli S; Sau G; Bolasco P; Pedrini LA; Basile C; David S; Feriani M; Nebiolo PE; Ferrara R; Casu D; Logias F; Tarchini R; Cadinu F; Passaghe M; Fundoni G; Villa G; Di Iorio BR; Zoccali C
    Nephrol Dial Transplant; 2012 Sep; 27(9):3594-600. PubMed ID: 22622452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical parameters after switching to nocturnal haemodialysis: a Dutch propensity-score-matched cohort study comparing patients on nocturnal haemodialysis with patients on three-times-a-week haemodialysis/haemodiafiltration.
    Jansz TT; Özyilmaz A; Grooteman MPC; Hoekstra T; Romijn M; Blankestijn PJ; Bots ML; van Jaarsveld BC
    BMJ Open; 2018 Mar; 8(3):e019900. PubMed ID: 29523566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time savings of weekly versus three-times-per-week administration of erythropoiesis stimulating agents in United States dialysis patients.
    Stephens JM; Emerson LC; Spry LA; Caloyeras JP; Anderson ER; Reitan JF; Ashfaq A
    Curr Med Res Opin; 2016; 32(2):313-20. PubMed ID: 26583202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM study.
    Donck J; Gonzalez-Tabares L; Chanliau J; Martin H; Stamatelou K; Manamley N; Farouk M; Addison J
    Adv Ther; 2014 Nov; 31(11):1155-68. PubMed ID: 25367412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.